Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Baker

Showing results (161-170 of 200) with videos related to

Pageof 20
Sort By:
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|September 6, 2019
Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized studyH Henry Li, Bruce Zuraw, Hilary J Longhurst, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2010
Identification and hit-to-lead optimization of a novel class of CB1 antagonistsJeffrey J Letourneau, Patrick Jokiel, John Olson, et al.
The Journal of Allergy and Clinical Immunology|December 31, 2021
Safety of peanut (Arachis hypogaea) allergen powder-dnfp in children and teenagers with peanut allergy: Pooled summary of phase 3 and extension trialsKari R Brown, James Baker, Andrea Vereda, et al.
Bioorganic & Medicinal Chemistry Letters|June 25, 2011
Optimisation of pharmacokinetic properties to afford an orally bioavailable and selective V1A receptor antagonistWilliam Arbuckle, James Baker, David Barn, et al.
Bioorganic & Medicinal Chemistry Letters|September 26, 2015
Identification of N-(1H-pyrazol-4-yl)carboxamide inhibitors of interleukin-1 receptor associated kinase 4: Bicyclic core modificationsJongwon Lim, Michael D Altman, James Baker, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 6, 2021
Blocking the IL-1 receptor reduces cardiac transplant ischemia and reperfusion injury and mitigates CMV-accelerated chronic rejectionIris K A Jones, Susan Orloff, Jennifer M Burg, et al.
Frontiers in Immunology|January 23, 2024
Dissecting tumor microenvironment heterogeneity in syngeneic mouse models: insights on cancer-associated fibroblast phenotypes shaped by infiltrating T cellsMarco Carretta, Marie-Louise Thorseth, Aimilia Schina, et al.
Journal of Endourology|January 5, 2021
A Novel Method for GreenLight MoXy Laser Fiber Irrigation System to Improve Performance and Durability: A New Standard of Care?Kyle W Law, Ahmed S Zakaria, Dean S Elterman, et al.
JBMR Plus|November 11, 2025
Identification of novel collagen breakdown products by human osteoclasts in vitro and in vivoBrendan P Norman, Jane P Dillon, Sahem M Alkharabsheh, et al.
ERJ Open Research|March 26, 2024
ERS International Congress 2023: highlights from the Airway Diseases AssemblyLaura Bergantini, James Baker, Apostolos Bossios, et al.
Pageof 20

Showing results (161-170 of 200) with videos related to

Sort By:
Pageof 20
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|September 6, 2019
Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized studyH Henry Li, Bruce Zuraw, Hilary J Longhurst, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2010
Identification and hit-to-lead optimization of a novel class of CB1 antagonistsJeffrey J Letourneau, Patrick Jokiel, John Olson, et al.
The Journal of Allergy and Clinical Immunology|December 31, 2021
Safety of peanut (Arachis hypogaea) allergen powder-dnfp in children and teenagers with peanut allergy: Pooled summary of phase 3 and extension trialsKari R Brown, James Baker, Andrea Vereda, et al.
Bioorganic & Medicinal Chemistry Letters|June 25, 2011
Optimisation of pharmacokinetic properties to afford an orally bioavailable and selective V1A receptor antagonistWilliam Arbuckle, James Baker, David Barn, et al.
Bioorganic & Medicinal Chemistry Letters|September 26, 2015
Identification of N-(1H-pyrazol-4-yl)carboxamide inhibitors of interleukin-1 receptor associated kinase 4: Bicyclic core modificationsJongwon Lim, Michael D Altman, James Baker, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 6, 2021
Blocking the IL-1 receptor reduces cardiac transplant ischemia and reperfusion injury and mitigates CMV-accelerated chronic rejectionIris K A Jones, Susan Orloff, Jennifer M Burg, et al.
Frontiers in Immunology|January 23, 2024
Dissecting tumor microenvironment heterogeneity in syngeneic mouse models: insights on cancer-associated fibroblast phenotypes shaped by infiltrating T cellsMarco Carretta, Marie-Louise Thorseth, Aimilia Schina, et al.
Journal of Endourology|January 5, 2021
A Novel Method for GreenLight MoXy Laser Fiber Irrigation System to Improve Performance and Durability: A New Standard of Care?Kyle W Law, Ahmed S Zakaria, Dean S Elterman, et al.
JBMR Plus|November 11, 2025
Identification of novel collagen breakdown products by human osteoclasts in vitro and in vivoBrendan P Norman, Jane P Dillon, Sahem M Alkharabsheh, et al.
ERJ Open Research|March 26, 2024
ERS International Congress 2023: highlights from the Airway Diseases AssemblyLaura Bergantini, James Baker, Apostolos Bossios, et al.
Pageof 20